At the mechanistic analysis level, the integration of transcriptomics and proteomics cross-analysis revealed that the drug primarily reverses the metabolic-immune imbalance in the AP model by regulating biological processes such as antibacterial humoral immunity and the IL-17 signaling pathway. Here, IL17A is linked to alkaline phosphatase measurement.